298. Hereditary pancreatitis Clinical trials / Disease details
Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00658736 (ClinicalTrials.gov) | March 2008 | 9/4/2008 | Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis | A Randomized, Triple-Blinded Study of Endoscopic Ultrasound Guided Celiac Plexus Blockade (EUS-CPB) With Bupivicaine and Triamcinolone vs. Bupivicaine Alone for the Treatment of Pain in Chronic Pancreatitis | Chronic Pancreatitis | Drug: Triamcinolone;Drug: Bupivicaine alone | The Cleveland Clinic | American Society for Gastrointestinal Endoscopy;TAP Pharmaceutical Products Inc. | Completed | 18 Years | N/A | All | 40 | Phase 3 | United States |
| 2 | NCT00583271 (ClinicalTrials.gov) | June 2002 | 20/12/2007 | A Prospective Study of EUS Guided Celiac Block | A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness | Chronic Pancreatitis;Pancreatic Cancer | Drug: triamcinolone;Drug: 98% dehydrated alcohol | Indiana University | NULL | Completed | 18 Years | N/A | Both | 127 | N/A | United States |